Printer friendly
Acronymfinder

What does IGFBP-3 stand for?

IGFBP-3 stands for Insulin-like Growth Factor Binding Protein-3


This definition appears very rarely and is found in the following Acronym Finder categories:

  • Science, medicine, engineering, etc.

Samples in periodicals archive:

3 million related to Tercica's exclusive license to Genentech's worldwide rights to Insulin-like Growth Factor-1 (IGF-1) combined with Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) for all indications, other than diseases and conditions of the central nervous system and, outside of the US, diabetes.
3, 2003 Study Shows rhIGFBP-3 Enhances Sensitivity to Herceptin(R) (Trastuzumab) in Models of Herceptin(R) Resistant Breast Cancer Insmed Incorporated (Nasdaq-NMS: INSM) (Nasdaq: INSM) reported today that data from recent studies of the Company's proprietary anti-cancer compound, recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3), will be presented at The 26th Annual San Antonio Breast Cancer Symposium (SABCS), to be held at the Henry B.
17, 2003 Study shows rhIGFBP-3 Enhances Sensitivity to Radiation Therapy and Inhibits Tumor Formation in a Model of Human Breast Cancer Insmed Incorporated (Nasdaq: INSM) reported today that data from recent studies of the Company's proprietary anti-cancer compound, recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3), will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, November 17-21, at the Hynes Center in Boston.
The abstract titled, "Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3) as a potential therapeutic agent for the treatment of Herceptin(R)-resistant breast cancer" will be presented at The 26th Annual San Antonio Breast Cancer Symposium (SABCS), to be held at the Henry B.
BUSINESS WIRE)--July 14, 2003 Insmed Incorporated (Nasdaq:INSM) reported today that data from recent studies of the Company's proprietary anti-cancer compound, recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3), were presented at the rescheduled 94th Annual Meeting of the American Association of Cancer Research.